Akari Therapeutics Plc (AKTX)
0.2703
0.00 (0.00%)
USD |
NASDAQ |
Jan 15, 16:00
0.2793
+0.01
(+3.33%)
After-Hours: 17:42
Akari Therapeutics SG&A Expense (TTM): 10.20M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| DBV Technologies SA | 28.71M |
| Cellectis SA | 19.93M |
| Biodexa Pharmaceuticals Plc | 5.354M |
| NuCana Plc | 9.964M |
| Autolus Therapeutics Plc | 129.58M |